Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cirtran (CIRX) EBITDA Margin (2017 - 2025)

Historic EBITDA Margin for Cirtran (CIRX) over the last 14 years, with Q3 2025 value amounting to 37.13%.

  • Cirtran's EBITDA Margin rose 496600.0% to 37.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 45.5%, marking a year-over-year decrease of 350300.0%. This contributed to the annual value of 42.47% for FY2024, which is 415500.0% down from last year.
  • According to the latest figures from Q3 2025, Cirtran's EBITDA Margin is 37.13%, which was up 496600.0% from 114.74% recorded in Q2 2025.
  • Over the past 5 years, Cirtran's EBITDA Margin peaked at 130.39% during Q4 2023, and registered a low of 1025.82% during Q4 2022.
  • In the last 5 years, Cirtran's EBITDA Margin had a median value of 20.57% in 2021 and averaged 75.72%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 39420900bps in 2021, then tumbled by -10052400bps in 2022.
  • Cirtran's EBITDA Margin (Quarter) stood at 20.57% in 2021, then crashed by -4886bps to 1025.82% in 2022, then surged by 113bps to 130.39% in 2023, then crashed by -165bps to 85.04% in 2024, then soared by 56bps to 37.13% in 2025.
  • Its EBITDA Margin was 37.13% in Q3 2025, compared to 114.74% in Q2 2025 and 9.39% in Q1 2025.